Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Data describing nucleotide substitution patterns within the conserved regions of the homing endonuclease domains of pairs of full-length PRP8 inteins. Sd is the number of observed synonymous substitutions; Nd is the number of observed non-synonymous substitutions; S is the number of potential synonymous substitutions; N is the number of potential non synonymous substitutions; pS is the proportion of observed synonymous substitutions; pN is the proportion of observed non-synonymous substitutions; dS is the Jukes-Cantor correction for multiple hits of pS; dN is the Jukes-Cantor correction for multiple hits of pN. Inteins are identified using strain names as shown in Table 1.

From: The distribution and evolutionary history of the PRP8 intein

Seq1 Seq2 Sd Nd S N pS pN dS dN dS/dN
Hca186AR Hca217B 2.00 1.00 47.17 165.83 0.04 0.01 0.04 0.01 7.21
Hca186AR BciPRP8 31.62 40.38 47.17 165.83 0.67 0.24 1.68 0.29 5.72
Hca186AR PbrPRP8 36.00 32.00 48.67 164.33 0.74 0.19 3.22 0.23 14.27
Hca186AR AniPRP8 41.88 38.12 46.50 166.50 0.90 0.23 NA 0.27 NA
Hca186AR Afu0163 38.12 35.88 48.67 164.33 0.78 0.22 NA 0.26 NA
Hca186AR Afu5109 38.12 36.88 48.33 164.67 0.79 0.22 NA 0.27 NA
Hca186AR Nfi0181 36.38 33.62 48.33 164.67 0.75 0.20 NA 0.24 NA
Hca186AR ClaPRP8 39.75 62.25 48.67 161.33 0.82 0.39 NA 0.54 NA
Hca217B BciPRP8 31.12 39.88 47.67 165.33 0.65 0.24 1.53 0.29 5.27
Hca217B PbrPRP8 35.50 31.50 49.17 163.83 0.72 0.19 2.47 0.22 11.10
Hca217B AniPRP8 42.75 37.25 47.00 166.00 0.91 0.22 NA 0.27 NA
Hca217B Afu0163 37.62 35.38 49.17 163.83 0.77 0.22 NA 0.25 NA
Hca217B Afu5109 37.62 36.38 48.83 164.17 0.77 0.22 NA 0.26 NA
Hca217B Nfi0181 35.88 33.12 48.83 164.17 0.73 0.20 2.92 0.24 12.41
Hca217B ClaPRP8 39.00 60.00 49.17 160.83 0.79 0.37 NA 0.52 NA
BciPRP8 PbrPRP8 43.50 27.50 49.17 163.83 0.88 0.17 NA 0.19 NA
BciPRP8 AniPRP8 39.00 24.00 47.00 166.00 0.83 0.14 NA 0.16 NA
BciPRP8 Afu0163 39.50 16.50 49.17 163.83 0.80 0.10 NA 0.11 NA
BciPRP8 Afu5109 39.50 17.50 48.83 164.17 0.81 0.11 NA 0.11 NA
BciPRP8 Nfi0181 35.50 16.50 48.83 164.17 0.73 0.10 2.61 0.11 24.21
BciPRP8 ClaPRP8 36.75 46.25 49.50 160.50 0.74 0.29 3.45 0.36 9.48
PbrPRP8 AniPRP8 38.88 31.12 48.50 164.50 0.80 0.19 NA 0.22 NA
PbrPRP8 Afu0163 38.25 23.75 50.67 162.33 0.75 0.15 NA 0.16 NA
PbrPRP8 Afu5109 38.25 24.75 50.33 162.67 0.76 0.15 NA 0.17 NA
PbrPRP8 Nfi0181 40.25 22.75 50.33 162.67 0.80 0.14 NA 0.15 NA
PbrPRP8 ClaPRP8 38.88 48.12 51.00 159.00 0.76 0.30 NA 0.39 NA
AniPRP8 Afu0163 36.62 22.38 48.50 164.50 0.76 0.14 NA 0.15 NA
AniPRP8 Afu5109 35.62 22.38 48.17 164.83 0.74 0.14 3.21 0.15 21.44
AniPRP8 Nfi0181 38.62 20.38 48.17 164.83 0.80 0.12 NA 0.14 NA
AniPRP8 ClaPRP8 44.50 43.50 48.83 161.17 0.91 0.27 NA 0.33 NA
Afu0163 Afu5109 1.00 0.00 50.33 162.67 0.02 0.00 0.02 0.00 NA
Afu0163 Nfi0181 11.00 2.00 50.33 162.67 0.22 0.01 0.26 0.01 20.84
Afu0163 ClaPRP8 40.50 47.50 51.00 159.00 0.79 0.30 NA 0.38 NA
Afu5109 Nfi0181 12.00 2.00 50.00 163.00 0.24 0.01 0.29 0.01 23.38
Afu5109 ClaPRP8 41.50 47.50 50.67 159.33 0.82 0.30 NA 0.38 NA
Nfi0181 ClaPRP8 39.62 47.38 50.67 159.33 0.78 0.30 NA 0.38 NA